Literature DB >> 31174429

Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease.

Suzanne V Arnold1, James A de Lemos2, Robert S Rosenson3, Christie M Ballantyne4, Yuyin Liu5, Katherine E Mues6, Shushama Alam6, Mary Elliott-Davey6, Deepak L Bhatt7, Christopher P Cannon5,7, Mikhail Kosiborod1,8.   

Abstract

Entities:  

Keywords:  coronary artery disease; diabetes mellitus; quality of care

Mesh：

Substances：

Year:  2019        PMID： 31174429     DOI： 10.1161/CIRCULATIONAHA.119.041730

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  22 in total

Review 1.  Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration.

Authors:  Lee-Shing Chang; Muthiah Vaduganathan; Jorge Plutzky; Vanita R Aroda
Journal:  Curr Diab Rep       Date:  2019-12-04       Impact factor: 4.810

2.  Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs.

Authors:  Dhruv Mahtta; David J Ramsey; Michelle T Lee; Liang Chen; Mahmoud Al Rifai; Julia M Akeroyd; Elizabeth M Vaughan; Michael E Matheny; Karla Rodrigues do Espirito Santo; Sankar D Navaneethan; Carl J Lavie; Yochai Birnbaum; Christie M Ballantyne; Laura A Petersen; Salim S Virani
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

3.  Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes.

Authors:  Evangelos K Oikonomou; Marc A Suchard; Darren K McGuire; Rohan Khera
Journal:  Diabetes Care       Date:  2022-04-01       Impact factor: 19.112

Review 4.  Implementation of Cardiometabolic Centers and Training Programs.

Authors:  Mohamad B Taha; Neha Rao; Muthiah Vaduganathan; Miguel Cainzos-Achirica; Khurram Nasir; Kershaw V Patel
Journal:  Curr Diab Rep       Date:  2022-03-22       Impact factor: 4.810

5.  Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes.

Authors:  Merrill Thomas; Melissa Magwire; Kensey Gosch; Yasser Sammour; Rane Mehta; James O'Keefe; Michael E Nassif; Mikhail Kosiborod
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-09-30

6.  2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.

Authors:  Sandeep R Das; Brendan M Everett; Kim K Birtcher; Jenifer M Brown; James L Januzzi; Rita R Kalyani; Mikhail Kosiborod; Melissa Magwire; Pamela B Morris; Joshua J Neumiller; Laurence S Sperling
Journal:  J Am Coll Cardiol       Date:  2020-08-05       Impact factor: 24.094

7.  Translating the Secondary Prevention Therapeutic Boom Into Action.

Authors:  Michael G Nanna; Eric D Peterson
Journal:  JAMA Cardiol       Date:  2020-02-01       Impact factor: 14.676

8.  National Trends in Use of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020.

Authors:  Rishav Adhikari; Kunal Jha; Zeina Dardari; James Heyward; Roger S Blumenthal; Robert H Eckel; G Caleb Alexander; Michael J Blaha
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

Review 9.  Targeting multiple domains of residual cardiovascular disease risk in patients with diabetes.

Authors:  Kershaw V Patel; Muthiah Vaduganathan
Journal:  Curr Opin Cardiol       Date:  2020-09       Impact factor: 2.161

Review 10.  Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of Care.

Authors:  Stephan Jacob; Andrew J Krentz; John Deanfield; Lars Rydén
Journal:  Drugs       Date:  2021-07-24       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.